INTRODUCTION
Spermatogenesis, the multistep process by which spermatogonial stem cells give rise to mature spermatozoa, takes place within the seminiferous tubules of the mammalian testis. The seminiferous tubules contain three major cell types: peritubular cells, which form the exterior wall of the seminiferous tubule, germ cells in various stages of development, and Sertoli cells, which relay external signals and provide factors required for the differentiation and proliferation of germ cells. Spermatogenesis is under hormonal control by the hypothalamic-pituitary-testicular axis as well as through local testicular paracrine mechanisms (1, 2) . A major hormonal regulator of spermatogenesis is the pituitary gonadotropin, FSH, which acts on Sertoli cells to stimulate increases in cAMP levels leading to the activation of PKA and subsequent induction of genes essential for the process of spermatogenesis (3, 4) . In addition, a number of cytokines including interleukin-1 (IL-1), IL-6, and tumor necrosis factor-␣ (TNF-␣), have been shown to be paracrine regulators of testis gene expression (5) (6) (7) (8) (9) (10) (11) . Interestingly, PKA as well as the cytokines IL-1, IL-6, and TNF-␣, share the ability to activate the nuclear factor (NF)-B transcription factor (12) (13) (14) (15) (16) . A number of genes expressed in the testis, including the androgen receptor, urokinase, proenkephalin, and TNF-␣ genes, have been shown to be regulated by NF-B in other tissues (17) (18) (19) (20) (21) (22) . Due to the potential importance of NF-B in regulating testis gene expression, we wished to test the hypothesis that NF-B is induced in testis seminiferous tubules.
Five NF-B DNA-binding subunits (Rel A or p65, Rel B, c-Rel, p50, and p52) have been identified in mammalian cells. The NF-B (Rel) family of transcription factors regulate transcription by binding as dimers to B enhancer elements in the regulatory region of genes. With few exceptions, NF-B proteins remain in the cytoplasm of unstimulated cells where they are tethered to various isoforms of IB (15, 23, 24) . Upon stimulation, IB is phosphorylated and undergoes proteosome-mediated degradation, thereby releasing NF-B to translocate to the nucleus and regulate gene transcription (24, 25) . In addition to regulated nuclear translocation, NF-B activity can be altered by phosphorylation of individual subunits. Direct phosphorylation of NF-B p65 by PKA or PKC has been shown to enhance p65 DNA binding and transactivation activity (16, 26, 27) .
With this study we have determined that NF-B is constitutively present and active in the nuclei of Sertoli 0888-8809/98/$3.00/0 Molecular Endocrinology Copyright © 1998 by The Endocrine Society cells cultured from rat testis. In the testis, nuclear expression of NF-B proteins was found to be regulated in a cell-and stage-specific manner. Sertoli cell levels of nuclear NF-B were highest during spermatogenesis stages XIV-VII, whereas nuclear expression of NF-B peaked in stage VII-XI spermatocytes. Treatment of Sertoli cells with TNF-␣, which is expressed by spermatids, increased NF-B binding activity. Sertoli cell nuclear NF-B DNA-binding activity was also enhanced by the PKA activators forskolin and FSH. NF-B was shown to be functional as basal levels of B enhancer-mediated transcription were high in Sertoli cells, and addition of TNF-␣ further stimulated gene expression. These data identify NF-B as a potential regulator of the genetic program of spermatogenesis.
RESULTS

Constitutive Nuclear Expression of NF-BBinding Activity in Sertoli Cells
To explore the potential role of NF-B in spermatogenesis, the expression of NF-B was first tested in electrophoretic mobility shift assays (EMSAs) using nuclear protein extracts from primary Sertoli cell cultures and a probe containing a consensus B enhancer motif. A series of DNA-protein complexes were formed (Fig. 1A) . The proteins forming the complexes were shown to specifically bind the B enhancer probe: a 50-fold excess of the homologous B enhancer oligonucleotide eliminated all complex formation, but a 50-fold excess of oligonucleotides containing a Sp1-binding site or a cAMP response element (CRE) did not affect probe-protein interactions Further characterization of NF-B proteins was performed using nuclear and cytoplasmic extracts from TM4 and MSC-1 Sertoli cell lines in addition to primary Sertoli cells. In unstimulated cells, NF-B is typically retained in the cytoplasm. In contrast, substantial NF-B-binding activity was detected in nuclear extracts from all the Sertoli cell lines, with nuclear binding activity similar to that of the corresponding cytoplasmic extracts. The binding activities of nuclear and cytoplasmic extracts were also compared with cytoplasmic extracts that were pretreated with deoxycholate (DOC), a detergent known to dissociate IB from NF-B in vitro (28) . Treatment of cytoplasmic extracts with DOC enhanced the formation of DNA-protein complexes from primary and TM4 Sertoli cells 3-and 1.5-fold, respectively, but had less effect on MSC-1 cells (1.2-fold induction). Furthermore, detergent treatment allowed detection of the B1 complex in primary Sertoli cells that was otherwise only visualized after long film exposure times (Fig. 1B) . In comparison to primary Sertoli cells, the B1 complex was less prevalent in extracts from the Sertoli cell lines. However, TM4 and MSC-1 cell extracts formed one complex that was similar to that from primary cells (B2) and another complex (B3) that migrated slightly slower than the B3 complex from primary Sertoli cells. The migration pattern of the B3 complex was found to vary slightly when various protein extract preparations were used. In some cases, a less abundant lower complex could be resolved, but due to the inability to reproducibly separate the complexes, all the DNAprotein interactions in this region were characterized as B3.
The Major Forms of NF-B in Sertoli Cells Are p50 and p65
Further studies were undertaken to characterize the Sertoli cell proteins binding to the B enhancer motifs. UV cross-linked DNA-protein complexes formed using a photoaffinity, 32 P-labeled B enhancer probe were fractionated by SDS-PAGE to resolve the proteins covalently bound to the probe. Complexes formed using extracts from COS-1 cells transfected with NF-B p50 or p65 expression vectors were compared with complexes from unstimulated TM4, MSC-1, and primary Sertoli cell nuclear extracts. Previous studies have shown that the probe contributes approximately 5 kDa to the apparent molecular mass of the DNA-protein complex (29) . A complex of 70 kDa that comigrates with the p65-containing complex from transfected COS-1 cells was detected in the B1 band from MSC-1 and primary Sertoli cells and the B2 bands from TM4, MSC-1, and primary Sertoli extracts (Fig. 1C) . Lower levels of a 55-kDa adduct were detected in the B2 complex that comigrated with the complex formed from p50 expressing Cos cells. The 55-kDa complex, but not the 70 kDa adduct, was detected in all B3 complexes. The B2 and B3 complexes also contained varying levels of an additional 40-kDa adduct, which may represent partial p50 proteolysis or an additional B element-binding protein. The 150-kDa adduct detected in the B1 and B2 complexes and the 110-kDa adduct present in the B3 complex may represent p65 dimers, p65-p50 heterodimers, or p50 dimers simultaneously cross-linked to the probe. Together, the UV cross-linking studies identify three types of NF-B complexes formed in Sertoli cells. B1 complexes contain predominately p65 homodimers, B2 consists of p50 and p65 heterodimers, and B3 contains p50 homodimers and an unidentified protein of approximately 40 kDa.
To confirm that NF-B p50 and p65 are present in Sertoli cells, antisera against p50 and p65 were used in immunoprecipitation assays of primary Sertoli whole-cell extracts (Fig. 1D ). Both NF-B p50 and p65 were immunoprecipitated from the Sertoli extracts by their respective antisera. Together, the data from Fig. 1 indicate that p50 and p65 are major forms of B enhancer-binding proteins present in Sertoli cells. . DNA-protein complexes were resolved by nondenaturing PAGE and detected by autoradiography. For all EMSAs the unbound probe was run off of the gel. B, Sertoli nuclear extracts contain high levels of NF-B-binding activity. Equal amounts of nuclear (NE) and cytoplasmic (Cyto) extracts from primary Sertoli cells (5 g, lanes 1-3), as well as TM4 (10 g, lanes 4-6) and MSC-1 (5 g, lanes 7-9) Sertoli cell lines, were incubated with a 32 P-labeled B enhancer probe. Cytoplasmic extracts were also preincubated in the presence of DOC and NP-40 detergents (lanes 3, 6, and 9, Cyto ϩ Det). The various DNA-protein complexes formed (B1-B3) are indicated. The determination of the relative levels of DNA-protein complexes is explained in Materials and Methods. C, UV cross-linking of Sertoli nuclear proteins to the B enhancer. DNA-protein complexes derived from Cos-1 cells expressing p65 or p50 homodimers (lanes 1, 2) as well as various B1, B2, and B3 complexes from TM4 (lanes 3, 4), MSC-1 (lanes 5-7), and primary Sertoli cells (lanes 8-10) were resolved by nondenaturing PAGE, UV cross-linked in situ, excised from the gel, and separated by denaturing discontinuous SDS-PAGE. The DNA-protein adducts containing NF-B p50 and p65 are indicated.
NF-B p50 and p65 Are Localized in a StageSpecific Manner to the Nuclei of Sertoli and Germ Cells in Vivo
To confirm the nuclear localization of NF-B proteins shown by the DNA-binding assays, primary Sertoli cells were probed with p65 and p50 specific antisera in immunohistochemistry studies. Primary Sertoli cells were found to have high levels of p50 and p65 staining in the nucleus, although some cytoplasmic staining was also evident (Fig. 2) . In contrast, immunostaining of NIH 3T3 cells showed p50 and p65 to be predominately cytoplasmic, in agreement with earlier studies (30) . Transferring primary Sertoli cells from a defined serum-free media mixture to either DMEM with no supplements or DMEM with 10% serum for 48 h did not significantly alter the levels of nuclear NF-B immunostaining (data not shown). These results raised the possibility that Sertoli cells normally retain NF-B in the nucleus. Immunohistochemistry studies were extended to adult rat testis tissue to determine whether NF-B proteins localize to the nucleus of testis cells in vivo. Cross-sections from rat testis seminiferous tubules can be designated as containing one of 14 characteristic germinal cell association patterns (I-XIV) or stages of spermatogenesis (31, 32) . In the rat these stages repeat in cycles of 12.5 days resulting in the cycle of the seminiferous epithelium. Rat testis tissue sections were probed with NF-B p50 and p65 antisera. Both the cytoplasm and the nucleus of Sertoli cells were immunostained by p50 and p65 antisera (Fig. 3 , A-E). It should be noted that direct comparison of Sertoli cytoplasmic vs. nuclear immunostaining is difficult due to dilution of antigen in the 5-fold larger volume of the cytoplasm that extends from the basement membrane to the tubule lumen. Immunostaining of the Sertoli cell cytoplasm surrounding the germ cells was not noticeably different in the various cell association stages; however, the staining of Sertoli cell nuclei along the basement membrane of seminiferous tubules varied in a stage-specific manner. Immunostained Sertoli nuclei could be detected in all cell association stages, but nuclear NF-B levels were elevated in spermatogenesis stages XIV-VII. In contrast, spermatocyte germ cells show a stage-specific pattern of p50 and p65 nuclear localization with peak immunostaining during stages VII-XI. NF-B p50 and p65 are also present in early spermatid nuclei during stages I-III immediately after spermatocytes undergo meiosis. In some cases lower levels of p50 immunostaining are seen as late as stage VII spermatids, but p50 and p65 are not detected in more mature spermatids. This pattern of staining indicates that NF-B proteins are not present in the nuclei of less mature leptotene and zygotene spermatocytes but are initially expressed in the nucleus during the pachytene stage of spermatocyte development. A summary of the relative levels of p65 immunostaining (quantitation of p50 immunostaining was very similar to p65) in Sertoli and spermatocyte Paraffin-embedded adult testis sections were immunostained with preimmune antisera (A) or antisera against the p50 subunit (B and D) or the p65 subunit (C and E) of NF-B. Panels D and E are higher magnification views from panels B and C, respectively. The brown staining is indicative of the immune avidin-biotin complex; nuclei have been counterstained blue with hematoxylin. Cell association stages are shown with Roman numerals. S, Sertoli cell nucleus; L, leptotene spermatocyte; P, pachytene spermatocyte; Sd, spermatid. An explanation of techniques used to quantitate the relative immunostaining intensity of nuclei is provided in Materials and Methods. The immunostaining experiments were performed at least four times.
nuclei at each stage of spermatogenesis is provided in Fig. 4 .
TNF-␣ and Phorbol 12-Myristate 13-Acetate (PMA) Induce NF-B-Binding Activity in Sertoli Cell Nuclei
The stage-specific increases in NF-B p50 and p65 subunit localization to Sertoli and spermatocyte nuclei suggested that nuclear accumulation of NF-B subunits could be induced in response to appropriate signals. One candidate inducer of NF-B in the testis is TNF-␣, which has been found to be secreted from spermatids in a spermatogenesis stage-specific manner (11) and to induce gene expression in Sertoli cells (33) . Addition of TNF-␣ to Sertoli cells resulted in a dramatic increase (13.5-fold) in nuclear NF-B-binding activity within 0.5 h that declined slightly after 2 and 6 h (12.5-and 8-fold above nontreated levels, respectively) (Fig. 5) . NF-B binding activity rose again to 10.5-fold higher than basal levels after 12 h of TNF-␣ stimulation and declined thereafter. The membranepermeable NF-B activator PMA was also able to increase nuclear NF-B binding activity 6.5-fold after 0.5 h of treatment with levels decreasing after 24 h of stimulation to 3.5-fold above the basal condition. Together, these data suggest that signaling pathways such as that initiated by TNF-␣ could induce additional nuclear NF-B-binding activity in Sertoli cells.
Inducers of cAMP and PKA Increase NF-B Binding Activity in Sertoli Cells
FSH is an important regulator of Sertoli cell function and spermatogenesis (1, 2) . Among the actions of FSH on Sertoli cells, in vivo, is the cyclical elevation of cAMP and the activation of PKA, a known regulator of NF-B (34) . The possibility that NF-B binding activity is increased by activators of PKA in Sertoli cells was tested in EMSA studies. The B enhancer probe was incubated with nuclear extracts from untreated primary Sertoli cells or from primary Sertoli cells stimulated with forskolin for 2 h to raise cAMP and PKA activity. NF-B binding activity was increased 4.5-fold after forskolin addition (Fig. 6) . Treating Sertoli cells with FSH also increased NF-B binding activity 2.5-fold with levels peaking 2 h after FSH addition and falling thereafter. The relative levels of NF-B p65 immunostaining in Sertoli (solid squares) and spermatocyte (open circles) nuclei are shown for each stage of spermatogenesis (germ cell association stages I-XIV; note that data for stages II and III are combined) during the 12-day cycles of germ cell development. An explanation of techniques used to quantitate the relative immunostaining intensity of nuclei is provided in Materials and Methods. Immunostaining intensity levels are given as arbitrary units relative to the mean immunostaining of stage I Sertoli nuclei (ϭ100%). Three independent experiments were used to generate the values shown. 
B-Mediated Transcription Is Constitutively Stimulated in Sertoli Cells
The transcriptional effects of NF-B proteins in testis cells were studied using the BLUC expression vector, which contains the tandem B enhancer elements of the human immunodeficiency virus-1 (HIV-1) long terminal repeat (LTR) linked to a TATA box minimal promoter driving the luciferase reporter gene. In unstimulated MSC-1 and primary Sertoli cells, BLUC activity was at least 50-fold greater than the pGL2LUCBasic parent vector and 6-to 8-fold greater than SV40LUC having the luciferase gene driven by the SV40 promoter (Fig. 7) . Cotransfection of NF-B p50 and p65 expression vectors into MSC-1 and primary Sertoli cells caused a further 3 to 4-fold induction of the BLUC reporter gene. Addition of TNF-␣ also induced BLUC in primary Sertoli cells (3.2-fold, Fig. 7 ) and in MSC-1 cells (5.1-fold, data not shown). In contrast, stimulation of Sertoli cells with FSH or forskolin did not increase BLUC activity (data not shown). To determine whether the high basal levels of B enhancermediated gene expression were due to NF-B proteins, an expression vector encoding an aminoterminal deletion mutant of IB␣ was added to the transfection mixtures. The IB␣ mutant used is resistant to phosphorylation-mediated degradation and therefore is incapable of releasing NF-B (35). Expression of the IB␣ mutant abolished B enhancerdirected transcription in MSC-1 and primary Sertoli cells. The down-regulation of gene expression after sequestration of NF-B by the dominant negative IB mutant confirmed that free nuclear NF-B was responsible for activating transcription through B enhancers in Sertoli cells.
DISCUSSION
Spermatogenesis is a complex process requiring precisely timed hormonal and paracrine signals to regulate the genetic pathways responsible for proliferation and differentiation of germ cells. The NF-B transcription factor has the capability to respond to a diverse range of stimuli ultimately leading to modified gene expression (15, 23) . Because the availability of NF-B stimulators such as TNF-␣ and PKA are controlled during spermatogenesis in a stage-specific manner (3, 11), we explored the possibility that NF-B may be induced in seminiferous tubules during the various stages of germ cell development. Our initial studies revealed that primary Sertoli cells and Sertoli cell lines are unusual in that NF-B-binding activity in nuclear extracts was equal to or greater than that present in crude cytoplasmic extracts. Despite the increased nuclear NF-B activity, significant levels of NF-B were found to be present in the Sertoli cell cytoplasm, and additional NF-B activity could be liberated from IB by detergent treatment. Compared with primary Sertoli cells, the transformed Sertoli cell lines released less NF-B binding activity after detergent treatment. It is possible that the transformed Sertoli cell lines may maintain less NF-B in the cytoplasm or are less efficient in the release of NF-B from cytoplasmic stores. This hypothesis would be consistent with the finding that the B1 band was only amplified by detergent treatment of primary Sertoli cell cytoplasmic extracts.
DNA binding and immunoprecipitation studies identified NF-B p50 and p65 as the most prevalent isoforms of NF-B present in the nuclei and cytoplasm of Sertoli cells. Furthermore, immunohistochemical examination of testis tissue showed that NF-B p50 and p65 were present in Sertoli nuclei and cytoplasm throughout the spermatogenic cycle. Cytoplasmic staining of NF-B did not vary greatly, but nuclear levels fluctuated in a stage-specific manner. Sertoli cell nuclear NF-B levels were found to peak in stages XIV-VII and then fall in stages VIII-XIII. The pattern of NF-B immunostaining shown throughout the cycle of spermatogenesis demonstrated that Sertoli cells constitutively express nuclear NF-B in vivo. Furthermore, the increase in nuclear NF-B during stages XIV-VII suggests that additional NF-B is made available to potentially regulate stage-specific gene expression in Sertoli cells.
In developing germ cells, nuclear expression of NF-B first rose above baseline levels in pachytene spermatocytes during stage IV, peaked during stages VII-XI, and declined to lower levels in stage XII-XIV spermatocytes and the subsequent early spermatid stages I-VII. The decline in NF-B p50 and p65 levels in maturing spermatids was not unusual, as the expression of many transcription factors diminish in the later stages of spermatid development when most transcriptional activity ceases (36) . The stage-specific elevations in nuclear NF-B expression indicated that it may be required for gene induction during these stages of spermatogenesis.
Stimulation of primary Sertoli cells with the NF-B activating factors PMA or TNF-␣ resulted in the activation of NF-B DNA-binding activity. The TNF-␣ induction of NF-B occurred in a biphasic manner with a dramatic increase in NF-B-binding activity within 0.5 h of TNF-␣ addition followed by a gradual decrease over 6 h and a subsequent rise and fall of NF-B-binding activity at 12 and 24 h. This biphasic pattern of NF-B induction mirrored that seen in other systems and has been shown to be due to the different kinetics with which IB␣ and IB␤ are degraded and regenerated after TNF-␣ or PMA stimulation (37) .
Activation of NF-B by TNF-␣ in Sertoli cells is not unexpected as Sertoli cells express the 55-kDa TNF I receptor (11) . However, it may be more significant that round spermatid germ cells secrete TNF-␣ in a stagespecific manner and that the increase in nuclear NF-B exhibited in stage I-VII Sertoli cells correlates with the presence of round spermatids in the seminiferous tubule (11, 38) . Furthermore, nuclear NF-B levels are lower during stages VIII-XIII when spermatids are elongating and producing less TNF-␣ (11). Although further study is required to confirm a direct link between TNF-␣ and NF-B activity in Sertoli cells, the TNF-␣ paracrine-regulatory system may be an important mechanism by which spermatids signal adjacent Sertoli cells to provide factors required during specific stages of development. In contrast, spermatocytes reportedly do not express receptors for TNF-␣ (11), and as suggested by the later peak in nuclear localization, must activate NF-B by another pathway.
The FSH-induced PKA activity in Sertoli cells (3) is another candidate regulator of NF-B activity in seminiferous tubules. Previous studies have shown that PKA is able to phosphorylate IB and initiate the release of NF-B to the nucleus (12, 14) . FSH induction of Sertoli cell cAMP and PKA is a cyclical process in vivo. cAMP levels begin to rise in stage XII, peak in stages III-V, and then fall to much lower levels during stages VI-XI (34). NF-B levels in Sertoli nuclei were also found to rise and fall in a cyclical manner, but the changes in NF-B nuclear immunolocalization appear to be slightly delayed (one to two stages) relative to changes in cAMP and PKA levels. Further study will be required to determine whether there is a direct relationship between FSH induction of Sertoli cellsignaling pathways and expression of nuclear NF-B in vivo.
PKA has also been shown to directly phosphorylate NF-B p65, resulting in increased affinity of p65 for the B enhancer sequence and increased transactivation activity (13, 26) . As the PKA activators FSH and forskolin increased NF-B binding activity in Sertoli cells, an unexpected finding was that these stimuli were unable to induce B enhancer-mediated transcription. One explanation for the lack of PKA-inducible transcription seen in cultured Sertoli cells may be the absence of a p65 cofactor. Recently, the PKA activation of B enhancer-regulated transcription was shown to be mediated by the functionally conserved transcriptional coactivators, CREB-binding protein and p300 (CBP/p300). PKA phosphorylation of p65 was found to promote association with the coactivators. Furthermore, NF-B-mediated transcription was induced by p65-CBP/p300 complexes in a PKA-dependent manner (16) . In many cell types CBP/p300 is present in limited quantities, and a number of transcription factors compete for coactivator binding (39) . It will be interesting to determine whether the availability of CBP/p300 in Sertoli cells modulates the NF-B response to FSH and PKA activation.
The best characterized model of nuclear localized, constitutively activated NF-B is the mature B cell. As B cells mature, the levels of nuclear p50 and c-Rel increase. The mechanisms underlying the constitutive NF-B activation in B cells is not yet fully understood, but recent studies suggest three possible explanations, including an increase in IB␣ turnover (40) , a decrease in IB␤ levels (41) , and/or an increase in a hypophosphorylated form of IB␤ that acts to prevent IB␣ interaction with NF-B subunits and does not interfere with nuclear translocation (42) . Although adult Sertoli cells are similar to mature B cells in that they are terminally differentiated, it remains to be determined whether Sertoli cells use similar mechanisms to maintain NF-B in the nucleus and whether these mechanisms are developmentally controlled.
The presence of preexisting nuclear NF-B proteins in Sertoli cells and their functional activity was shown in Sertoli cell transfection studies. The potent transcriptional enhancement mediated by the two tandem B repeats demonstrated that NF-B proteins are primed to activate transcription in untreated Sertoli cells. Down-regulation of gene expression after addition of a degradation-resistant form of IB confirmed that NF-B proteins were responsible for the high basal levels of B-enhancer-mediated transcription. The potential for additional gene induction in response to activators of NF-B was shown by the further stimulation of gene activity in Sertoli cells treated with TNF-␣.
Although these studies point out the potential for NF-B regulation of gene expression in Sertoli cells, it will be important to identify the genes modulated by NF-B and understand their regulation. Potential targets for NF-B regulation include the androgen receptor gene, which is required to mediate testosterone effects in the testis, and the urokinase gene, which is needed for the constant tissue remodeling performed during spermatogenesis. Both of these genes have been shown to be regulated by NF-B in other tissues (18) (19) (20) . In our studies we have noted that the CREB transcription factor promoter, which transmits signals received from the FSH-cAMP-PKA pathway (43) , also contains four putative B enhancer motifs (our unpublished data). A computer-assisted sequence analysis of 10 spermatogenesis-regulating genes expressed by Sertoli cells revealed 5 that contained consensus B enhancer motifs within their 5Ј-regulatory regions [gene sequences studied included the FSH receptor, androgen binding protein (ABP), Mullerian inhibiting substance (MIS), transferrin, TNF-␣ receptor I, c-mos, Hox 1.4, inhibin ␣, inhibin/actin ␤B chain, and stem cell factor]. The mouse MIS and stem cell factor, as well as the rat inhibin ␣, inhibin/actin ␤ B chain, and ABP genes, were all found to have putative NF-B-binding sites within 120-1250 bp of their transcription initiation sites. Due to the large number of genes that are potentially regulated by NF-B, further investigation into the mechanisms activating NF-B in Sertoli cells appears to be warranted.
MATERIALS AND METHODS
Isolation of Primary Sertoli Cells and Cell Culture
Sertoli cells were isolated from 16-day-old Sprague-Dawley rats as described previously (43) . Decapsulated testes were digested with collagenase (0.5 mg/ml, 33 C, 12 min) in enriched Krebs-Ringer bicarbonate media (EKRB) (44), followed by three washes in EKRB (1 ϫ g, 3 min) to isolate seminiferous tubules. Tubules were digested with trypsin (0.5 mg/ml, 33 C, 12 min), and cell aggregates were passed repeatedly through a drawn-out Pasteur pipette. An equal volume of DMEM containing 10% FCS was added to the Sertoli cells, which were then pelleted (500 ϫ g, 5 min) and resuspended in serum-free media containing 50% DMEM, 50% Ham's F12, 5 g/ml insulin, 5 g/ml transferrin, 10 Ϫ6 M retinoic acid, 10 ng/ml epidermal growth factor, 3 g/ml cytosine ␤-Darabinofurano-sidase, 2 mM glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 g/ml streptomycin. Sertoli cells were cultured on matrigel (Collaborative Research, Bedford, MA)-coated dishes (32 C, 5% CO 2 ). Sertoli cells were routinely Ͼ95% pure as determined by phase microscopy and alkaline phosphatase staining (45) . NIH 3T3 cells and mouse MSC-1 and TM4 Sertoli cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM glutamine (46) (47) (48) (49) . In some cases, cells were also cultured in the presence of forskolin (10 M) and isobutylmethylxanthine (IBMX) (0.5 mM), PMA (1 nM), or TNF-␣ (20 ng/ml). Animals used in these studies were maintained and killed according to the principles and procedures described in the NIH Guide for the Care and Use of Laboratory Animals.
Protein Extract Preparation
Nuclear and cytoplasmic extracts were prepared by detergent lysis (50) . Cells were lysed by incubation in buffer A [10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonylfluoride (PMSF), and a protease cocktail consisting of 0.5 ng/ml pepstatin A, and 5 ng/ml each of leupeptin, antipain, soybean trypsin inhibitor, and aprotinin] for 15 min on ice followed by the addition of 0.06% Nonidet P40. Cells were vortexed for 10 sec, and nuclei were collected by centrifugation (12,000 ϫ g, 30 sec). The supernatant containing cytoplasmic proteins was removed and frozen in 20% glycerol. To prepare nuclear extracts, pelleted nuclei were washed once with buffer A and resuspended in buffer C (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 20% glycerol, and the protease cocktail used for buffer A). Cells were mixed vigorously on a shaking platform (4 C, 15 min), the cell debris pellet was removed after centrifugation (5 min 12,000 ϫ g), and the supernatant containing nuclear proteins was frozen. Protein concentrations were determined by the Bradford method using the Bio-Rad protein assay.
DNA-Protein-Binding Assays
32 P-Radiolabeled DNA probes were generated by annealing a 27-nucleotide template containing a consensus B enhancer element (5Ј-CGACACCCCTCGGGAATTCCCC-CACTGGG-CC-3Ј) to a complementary 10-base primer and then filling in the overhang with Klenow in the presence of [␣-
32 P]dATP and 5 mM dCTP, dGTP, dTTP, and 5-bromo-2-deoxyuridine 5-triphosphate. EMSAs were performed as described (51) . Briefly, 32 P-labeled B probe was incubated with 2-10 g of nuclear, cytoplasmic, or whole-cell extracts from either COS-1 cells, TM4 or MSC-1 Sertoli cell lines, or 16-day rat primary Sertoli cell cultures. Binding reactions were incubated 15 min at room temperature in the presence of 1 g poly(dI-dC), 250 ng BSA, 5 mM DTT, 50-100 mM NaCl or KCl, 20 mM HEPES, and 1 mM EDTA. For competition EMSAs, a 50-fold excess of double-stranded unlabeled competitor oligonucleotides including a Sp1-binding site (GCTGCCTGTGGCCCGGGCGGCTGGGAGAAGCGG), a CRE motif (GATCCGGCTGACGTCATCAAGCTAGATC), or the unlabeled B probe were coincubated with labeled B probe and nuclear extracts. Protein-DNA complexes were resolved via PAGE under nondenaturing conditions in a Tris/borate/EDTA buffer. In binding reactions involving detergent treatment to release NF-B proteins from IB, proteins were preincubated with 0.5% DOC for 10 min followed by the addition of 1% Nonidet P40 (NP40) immediately before addition of the radiolabeled probe. To quantitate the relative levels of DNA-protein complexes, autoradiograms were digitized on a flatbed scanner, and NIH Image (version 1.57) analysis software was used to measure the intensity of individual bands. Values for fold induction of binding activity were determined relative to the binding activity (band intensity) of the nuclear extracts for each cell type (Fig. 1) or the untreated (0 h) control extracts (Figs. 5 and 6 ), and the mean fold induction was calculated from two ( Fig. 6) or three (Figs. 1 and 5) independent experiments.
In Situ UV Cross-Linking and Immunoprecipitation Assays DNA/protein binding reactions were performed as described (51) . For in situ UV cross-linking studies, DNA-protein complexes resolved via 5% nondenaturing PAGE were UV irradiated in situ for 15 min at 302 nm using a TMW-20 transilluminator. DNA-protein adducts were excised from the gel resolved by denaturing discontinuous SDS-PAGE and visualized by autoradiography. For immunoprecipitation experiments, primary Sertoli cells were cultured for 1 h in methionine-and cysteine-deficient, serum-free DMEM and a further 2 h after the addition of 35 S-labeleled methionine and cysteine. Cells were washed twice with PBS and lysed in 1 ml RIPA buffer (150 mM NaCl, 10 mM Tris (pH 7.5), 0.1% SDS, 1% DOC, 1% NP40, 1 mM PMSF, and protease inhibitor cocktail). Extracts from approximately 2 ϫ 10 8 cells were incubated with preimmune antisera or antisera directed against the 21 amino-terminal amino acids of p50 or p65 and precipitated using protein A Sepharose. Immunoprecipitated proteins were fractionated by SDS-PAGE and visualized by fluorography.
Immunocytochemistry
Immunostaining was performed on paraffin-embedded sections (5 m) from Bouin's fixed adult rat testis or primary Sertoli cells or NIH 3T3 cells cultured on glass coverslips. Testis sections were deparaffinized in xylene, rehydrated, and then permeabilized for 1 min in cold 100% methanol. The sections were microwaved on high power for 20 min in citrate buffer (10 mM citrate, 30 mM NaCl, pH 5.5) and then left undisturbed at room temperature for 20 min (52). The sections were washed two times for 5 min in PBS and blocked for 12 h in normal goat serum, 0.5% BSA, and 0.15% glycine at 4 C. Cultured cells were fixed in 4% paraformaldehyde for 5 min, permeablized for 1 min in ice-cold 100% MeOH, and dried completely followed by blocking 4-24 h with normal goat serum, 0.5% BSA, and 0.15% glycine. The testis tissue or cultured cells were then incubated 12-24 h with preimmune serum or rabbit polyclonal antiserum directed against the amino-terminal 21 amino acids of NF-B p65 or NF-B p50. For cultured cells, fluorescent Cy3 secondary goat antirabbit antiserum was added. For tissue sections, anti-rabbit biotinylated secondary antibody (Vectastain Elite ABC Kit, Vector Laboratories, Burlingame, CA) was added, and bound antibodies were detected as described by the kit instructions using AEC staining solution (0.02%, 3-amino-9-ethylcarbazole, 5% N,N-dimethyl formamide, 0.015% H 2 O 2 , and 0.1 M sodium acetate, pH 5.0) as the colorimetric reagent. Slides were washed in H 2 O and counterstained with hematoxylin. A charged coupled device (CCD) video camera system (Optronics, Chelmsford, MA) was used to capture images of stained cells or tubule cross-sections. The quantitation of the relative staining intensities of seminiferous tubule nuclei by p65 and p50 antisera was accomplished using BioQuant image analysis software (R & M Biometrics, Inc., Nashville, TN). Immunostained slides of adult rat testis tissue regularly contained at least 300 seminiferous tubule cross-sections. Testis tissue sections from three adult rats were used to quantitate relative nuclear immunostaining with one representative slide used from each animal. The testis tissue sections regularly contained at least 300 seminiferous tubule cross-sections. Sertoli cell and spermatocyte nuclei to be analyzed were chosen from the same tubules. At least five seminiferous tubule cross-sections representing each of the 14 (I-XIV) stages of spermatogenesis were chosen for quantitation from each slide. For each slide, threshold windows of red, green, and blue color values were set within the BioQuant image analysis program to distinguish only the redbrown staining of nuclei due to the AEC precipitate. Five of the stained nuclei from each tubule cross-section, as identified by the image analysis software, were randomly chosen and the immunostain within each nucleus was measured by a integrated optical density method that measures the intensity and density of pixels within an object as a function of object size. The mean integrated optical densities of nuclei in each stage was calculated (n Ն 25) and arbitrarily normalized to the mean value determined for stage I Sertoli nuclei (stage I ϭ 100%). The mean normalized nuclear immunostaining intensities from the three independent experiments were determined to give the final relative immunostaining intensities.
Plasmid Constructs, Transfections, and Luciferase Assays
COS-1 cells were transfected with NF-B expression vectors by using diethylaminoethyl-dextran, and whole-cell lysates were prepared after 48 h (53). For transient reporter transfections, the BLUC vector was constructed by inserting a 200-bp PvuIIXhoI fragment from B-TATA-CAT (containing two tandem B enhancer elements derived from the HIV-1 LTR linked to the albumen gene TATA element) (54) into the SmaI-XhoI sites directly upstream of the luciferase gene in the pGL2-Basic vector (Promega, Madison, WI). SV40LUC is the pGL2-Promoter plasmid (Promega) containing the SV40 promoter upstream of the luciferase gene in the pGL2Basic backbone. The RSVLUC plasmid is pA 3 RSV 400 LUC containing the enhancer and promoter of the 3Ј-LTR of Rous sarcoma virus (55) . NF-B expression vectors contain cDNAs for NF-B p50 (56) and p65 (57) positioned downstream of the cytomegalovirus (CMV) promoter/enhancer in the pCMV4 and pCMV5 expression vectors (58, 59) (pCMV4p50 (53) and pCMV5p65, respectively (60)). The IB deletion mutant cDNA IB␣⌬N containing sequences encoding amino acids 37-317 of IB␣ was inserted into the pCMV4 expression vector (35) . Primary Sertoli cells and MSC-1 cells were transfected as described (43) using 1 g of luciferase reporter plasmid and 1 g of empty pCMV expression vector or 1 g of pCMV expression vectors encoding p50 and p65 or IB␣⌬N in the absence or presence of 20 ng/ml TNF-␣. Luciferase assays were performed using a luminometer and the Promega luciferase assay system. Luciferase activity of the extracts was normalized for protein activity as determined by Bradford assay.
